These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28447792)

  • 1. "Liquid Crystalline Nanoparticles": Rationally Designed Vehicle To Improve Stability and Therapeutic Efficacy of Insulin Following Oral Administration.
    Agrawal AK; Kumar K; Swarnakar NK; Kushwah V; Jain S
    Mol Pharm; 2017 Jun; 14(6):1874-1882. PubMed ID: 28447792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
    Singh S; Kushwah V; Agrawal AK; Jain S
    Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
    Urimi D; Agrawal AK; Kushwah V; Jain S
    AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.
    Jain S; Bhankur N; Swarnakar NK; Thanki K
    Pharm Res; 2015 Oct; 32(10):3282-92. PubMed ID: 25968624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery.
    Elgindy NA; Mehanna MM; Mohyeldin SM
    Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
    Zeng N; Gao X; Hu Q; Song Q; Xia H; Liu Z; Gu G; Jiang M; Pang Z; Chen H; Chen J; Fang L
    Int J Nanomedicine; 2012; 7():3703-18. PubMed ID: 22888230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles.
    Jain S; Heeralal B; Swami R; Swarnakar NK; Kushwah V
    AAPS PharmSciTech; 2018 Jan; 19(1):460-469. PubMed ID: 28785860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system.
    Al-Remawi M; Elsayed A; Maghrabi I; Hamaidi M; Jaber N
    Pharm Dev Technol; 2017 May; 22(3):390-398. PubMed ID: 27470482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
    Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
    Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Jain S; Rathi VV; Jain AK; Das M; Godugu C
    Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships.
    Swarnakar NK; Thanki K; Jain S
    Mol Pharm; 2014 May; 11(5):1435-49. PubMed ID: 24742138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
    Shilpi D; Kushwah V; Agrawal AK; Jain S
    Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma.
    Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh S; Singh P; Guleria A; Saha S; Saraf SA
    Mol Pharm; 2021 Mar; 18(3):1102-1120. PubMed ID: 33356314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement.
    Jain S; Yadav P; Swami R; Swarnakar NK; Kushwah V; Katiyar SS
    AAPS PharmSciTech; 2018 May; 19(4):1699-1711. PubMed ID: 29532426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation.
    Badie H; Abbas H
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2013-2025. PubMed ID: 30095009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management.
    Freag MS; Torky AS; Nasra MM; Abdelmonsif DA; Abdallah OY
    Nanomedicine (Lond); 2019 Apr; 14(8):931-954. PubMed ID: 30925102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach.
    Waghule T; Dabholkar N; Gorantla S; Rapalli VK; Saha RN; Singhvi G
    Biomed Pharmacother; 2021 Sep; 141():111940. PubMed ID: 34328089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
    He Z; Santos JL; Tian H; Huang H; Hu Y; Liu L; Leong KW; Chen Y; Mao HQ
    Biomaterials; 2017 Jun; 130():28-41. PubMed ID: 28359018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes.
    Barauskas J; Cervin C; Jankunec M; Spandyreva M; Ribokaite K; Tiberg F; Johnsson M
    Int J Pharm; 2010 May; 391(1-2):284-91. PubMed ID: 20214966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.